{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:51:27Z","timestamp":1773449487453,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12325-021-01934-0","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T03:32:18Z","timestamp":1635305538000},"page":"5791-5808","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia"],"prefix":"10.1007","volume":"38","author":[{"given":"Ricardo","family":"Viana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"D\u2019Alessio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4291-931X","authenticated-orcid":false,"given":"Laura","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nichola","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mervyn","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drew","family":"Provan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Cuker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quentin A.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Tomiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed","family":"Ghanima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"issue":"3","key":"1934_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1365-2141.2008.07464.x","volume":"144","author":"JN George","year":"2009","unstructured":"George JN, Mathias SD, Go RS, et al. Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. Br J Haematol. 2009;144(3):409\u201315.","journal-title":"Br J Haematol"},{"issue":"3","key":"1934_CR2","first-page":"196","volume":"158","author":"D Blickstein","year":"2019","unstructured":"Blickstein D. Treatment of immune thrombocytopenic purpura in adults: update. Harefuah. 2019;158(3):196\u20139.","journal-title":"Harefuah"},{"key":"1934_CR3","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/B978-0-12-813456-6.00039-4","volume-title":"Platelets","author":"JM Despotovic","year":"2019","unstructured":"Despotovic JM, Bussel JB. Immune thrombocytopenia (ITP). In: Michelson A, Cattaneo M, Frelinger A, Newman P, editors. Platelets. London: Elsevier; 2019. p. 707\u201324."},{"key":"1934_CR4","doi-asserted-by":"crossref","unstructured":"Mithoowani S, Arnold DM. First-line therapy for immune thrombocytopenia. H\u00e4mostaseologie. 2019;39(3):259\u201365.","DOI":"10.1055\/s-0039-1684031"},{"key":"1934_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2147\/PROM.S140932","volume":"9","author":"P Trotter","year":"2018","unstructured":"Trotter P, Hill QA. Immune thrombocytopenia: improving quality of life and patient outcomes. Patient Relat Outcome Meas. 2018;9:369.","journal-title":"Patient Relat Outcome Meas"},{"key":"1934_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/ajh.26045","volume":"96","author":"N Cooper","year":"2021","unstructured":"Cooper N, Kruse A, Kruse C, et al. Immune thrombocytopenia (ITP) World Impact Survey (iWISh): patient and physician perceptions of diagnosis, signs and symptoms, and treatment. Am J Hematol. 2021;96:188\u201398.","journal-title":"Am J Hematol"},{"issue":"2","key":"1934_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/ajh.26045","volume":"96","author":"N Cooper","year":"2021","unstructured":"Cooper N, Kruse A, Kruse C, et al. Immune thrombocytopenia (ITP) World Impact Survey (iWISh): patient and physician perceptions of diagnosis, signs and symptoms, and treatment. Am J Hematol. 2021;96(2):188\u201398.","journal-title":"Am J Hematol"},{"issue":"12","key":"1934_CR8","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/17474086.2018.1548930","volume":"11","author":"HG Sest\u00f8l","year":"2018","unstructured":"Sest\u00f8l HG, Trangb\u00e6k SM, Bussel JB, Frederiksen H. Health-related quality of life in adult primary immune thrombocytopenia. Expert Rev Hematol. 2018;11(12):975\u201385.","journal-title":"Expert Rev Hematol"},{"issue":"22","key":"1934_CR9","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","volume":"3","author":"D Provan","year":"2019","unstructured":"Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780\u2013817.","journal-title":"Blood Adv"},{"key":"1934_CR10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-125766","volume-title":"The psychometric properties of the ITP Life Quality Index assessed in a large multinational \u201cReal-World\u201d cohort of immune thrombocytopaenia patients","author":"P Griffiths","year":"2019","unstructured":"Griffiths P, Grant L, Bonner N, et al. The psychometric properties of the ITP Life Quality Index assessed in a large multinational \u201cReal-World\u201d cohort of immune thrombocytopaenia patients. Washington, DC: American Society of Hematology; 2019."},{"key":"1934_CR11","unstructured":"Grant L, Bonner N, Harper A, et al., editors. Qualitative research to support the content validity of the Immune Thrombocytopenia (ITP) Life Quality Index (ILQI). Br J Haematol. 2018. Wiley 111 River St, Hoboken 07030-5774, NJ USA."},{"key":"1934_CR12","doi-asserted-by":"crossref","unstructured":"Cooper N, Kruse A, Kruse C, et al. Immune thrombocytopenia (ITP) World Impact Survey (I\u2010WISh): impact of ITP on health\u2010related quality of life. Am J Hematol. 2021;96(2):188\u2013198.","DOI":"10.1002\/ajh.26045"},{"issue":"2","key":"1934_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ajh.26036","volume":"96","author":"N Cooper","year":"2021","unstructured":"Cooper N, Kruse A, Kruse C, et al. Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): impact of ITP on health-related quality of life. Am J Hematol. 2021;96(2):199\u2013207.","journal-title":"Am J Hematol"},{"key":"1934_CR14","volume-title":"Development of the Work Productivity and Activity Impairment (WPAI) Questionnaire","author":"MC Reilly","year":"2008","unstructured":"Reilly MC. Development of the Work Productivity and Activity Impairment (WPAI) Questionnaire. New York: Reilly Associates; 2008."},{"issue":"1","key":"1934_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-8-81","volume":"8","author":"NW Scott","year":"2010","unstructured":"Scott NW, Fayers PM, Aaronson NK, et al. Differential item functioning (DIF) analyses of health-related quality of life instruments using logistic regression. Health Qual Life Outcomes. 2010;8(1):1\u20139.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"1934_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jclinepi.2008.06.003","volume":"62","author":"NW Scott","year":"2009","unstructured":"Scott NW, Fayers PM, Aaronson NK, et al. A simulation study provided sample size guidance for differential item functioning (DIF) studies using short scales. J Clin Epidemiol. 2009;62(3):288\u201395.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1934_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10705519909540118","volume":"6","author":"L Hu","year":"1999","unstructured":"Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model Multidiscip J. 1999;6(1):1\u201355.","journal-title":"Struct Equ Model Multidiscip J"},{"key":"1934_CR18","volume-title":"Principles and practice of structural equation modeling","author":"RB Kline","year":"2015","unstructured":"Kline RB. Principles and practice of structural equation modeling. London: Guilford; 2015."},{"issue":"2","key":"1934_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1177\/0013164418783530","volume":"79","author":"D Shi","year":"2019","unstructured":"Shi D, Lee T, Maydeu-Olivares A. Understanding the model size effect on SEM fit indices. Educ Psychol Meas. 2019;79(2):310\u201334.","journal-title":"Educ Psychol Meas"},{"key":"1934_CR20","volume-title":"Psychometric theory 3E","author":"JC Nunnally","year":"1994","unstructured":"Nunnally JC. Psychometric theory 3E. New York: Tata McGraw-Hill Education; 1994."},{"key":"1934_CR21","first-page":"20","volume":"2","author":"J Cohen","year":"1988","unstructured":"Cohen J. The t test for means. Stat Power Anal Behav Sci. 1988;2:20\u20136.","journal-title":"Stat Power Anal Behav Sci"},{"issue":"12","key":"1934_CR22","doi-asserted-by":"publisher","first-page":"e114468","DOI":"10.1371\/journal.pone.0114468","volume":"9","author":"R Froud","year":"2014","unstructured":"Froud R, Abel G. Using ROC curves to choose minimally important change thresholds when sensitivity and specificity are valued equally: the forgotten lesson of Pythagoras. Theoretical considerations and an example application of change in health status. PLoS ONE. 2014;9(12):e114468.","journal-title":"PLoS ONE"},{"issue":"5","key":"1934_CR23","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10979-005-6832-7","volume":"29","author":"ME Rice","year":"2005","unstructured":"Rice ME, Harris GT. Comparing effect sizes in follow-up studies: ROC area, Cohen\u2019s d, and r. Law Hum Behav. 2005;29(5):615\u201320.","journal-title":"Law Hum Behav"},{"key":"1934_CR24","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Erlbaum; 1988.","edition":"2"},{"key":"1934_CR25","doi-asserted-by":"publisher","DOI":"10.4324\/9781410604729","volume-title":"Test scoring","author":"DE Thissen","year":"2001","unstructured":"Thissen DE, Wainer HE. Test scoring. Mahwah: Erlbaum; 2001."},{"issue":"Supplement 1","key":"1934_CR26","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1182\/blood-2018-99-112378","volume":"132","author":"C Kruse","year":"2018","unstructured":"Kruse C, Kruse A, Watson S, et al. Patients with immune thrombocytopenia (ITP) frequently experience severe fatigue but is it under-recognized by physicians: results from the ITP World Impact Survey (I-WISh). Blood. 2018;132(Supplement 1):2273.","journal-title":"Blood"},{"issue":"S1","key":"1934_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/01.HS9.0000561132.23290.ae","volume":"3","author":"J Bussel","year":"2019","unstructured":"Bussel J, Tomiyama Y, Michel M, et al. PF712 physicians\u2019 perceptions on causes of primary and secondary ITP and leading causes of misdiagnosis: results from the ITP World Impact Survey (I-WISH). HemaSphere. 2019;3(S1):311.","journal-title":"HemaSphere"},{"issue":"S1","key":"1934_CR28","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/01.HS9.0000561140.08043.a7","volume":"3","author":"N Cooper","year":"2019","unstructured":"Cooper N, Kruse C, Kruse A, et al. PF714 patient perceptions on splenectomy outcomes: results from the ITP World Impact Survey (I-WISH). HemaSphere. 2019;3(S1):312.","journal-title":"HemaSphere"},{"issue":"4","key":"1934_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1177\/014662168801200410","volume":"12","author":"J Cohen","year":"1988","unstructured":"Cohen J. Set correlation and contingency tables. Appl Psychol Meas. 1988;12(4):425\u201334.","journal-title":"Appl Psychol Meas"},{"issue":"1","key":"1934_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","volume":"60","author":"CB Terwee","year":"2007","unstructured":"Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34\u201342.","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"1934_CR31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3390\/medicina56120667","volume":"56","author":"DR Terrell","year":"2020","unstructured":"Terrell DR, Neunert CE, Cooper N, et al. Immune thrombocytopenia (ITP): current limitations in patient management. Medicina (Kaunas). 2020;56(12):667.","journal-title":"Medicina (Kaunas)"},{"issue":"7","key":"1934_CR32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/MPH.0000000000000120","volume":"36","author":"CE Beck","year":"2014","unstructured":"Beck CE, Boydell KM, Stasiulis E, et al. Shared decision making in the management of children with newly diagnosed immune thrombocytopenia. J Pediatr Hematol Oncol. 2014;36(7):559\u201365.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"7","key":"1934_CR33","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/ajh.25110","volume":"93","author":"RF Grace","year":"2018","unstructured":"Grace RF, Despotovic JM, Bennett CM, et al. Physician decision making in selection of second-line treatments in immune thrombocytopenia in children. Am J Hematol. 2018;93(7):882\u20138.","journal-title":"Am J Hematol"},{"issue":"Supplement 1","key":"1934_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1182\/blood-2020-135970","volume":"136","author":"MK Kochhar","year":"2020","unstructured":"Kochhar MK, Grilo S, Robbins L, Catallozzi M, Neunert C. Decision aid to support shared decision making in pediatric refractory immune thrombocytopenia. Blood. 2020;136(Supplement 1):47\u20138.","journal-title":"Blood"},{"issue":"1","key":"1934_CR35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/njcp.njcp_84_20","volume":"24","author":"S Akin","year":"2021","unstructured":"Akin S, Haznedaroglu IC. Clinical variations between three different causes of thrombocytopenia. Niger J Clin Pract. 2021;24(1):17\u201320.","journal-title":"Niger J Clin Pract"},{"issue":"235","key":"1934_CR36","first-page":"65132","volume":"74","author":"US Food and Drug Administration","year":"2009","unstructured":"US Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. Fed Regist. 2009;74(235):65132\u20133.","journal-title":"Fed Regist"},{"issue":"8","key":"1934_CR37","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s11136-010-9677-6","volume":"19","author":"KE Lasch","year":"2010","unstructured":"Lasch KE, Marquis P, Vigneux M, et al. PRO development: rigorous qualitative research as the crucial foundation. Qual Life Res. 2010;19(8):1087\u201396.","journal-title":"Qual Life Res"},{"key":"1934_CR38","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1111\/j.1524-4733.2007.00275.x","volume":"10","author":"DL Patrick","year":"2007","unstructured":"Patrick DL, Burke LB, Powers JH, et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007;10:S125\u201337.","journal-title":"Value Health"},{"issue":"3","key":"1934_CR39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1083-6101.2010.01501.x","volume":"15","author":"JE Owen","year":"2010","unstructured":"Owen JE, Boxley L, Goldstein MS, Lee JH, Breen N, Rowland JH. Use of health-related online support groups: population data from the California health interview survey complementary and alternative medicine study. J Comput-Mediat Commun. 2010;15(3):427\u201346.","journal-title":"J Comput-Mediat Commun"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01934-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-021-01934-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01934-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T20:01:53Z","timestamp":1699732913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-021-01934-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1934"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01934-0","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]},"assertion":[{"value":"10 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}